1. Park M, Gwak G, Kim J, Cho H, Yang G, Lee Y, Park K. Clinicopatholgic Characteristics to the Relapse on Ductal Carcinoma In Situ : Ki-67 Index as the Most Influential Prognostic Factor. . J Breast Dis 2022 June;10(1):40-45

2. Lim S, Lee Y, Kim J, Cho H, Yang K, Park K, Kim J, Sin Y, Seo Y, Gwak G. Progesterone Receptor Expression as a Prognostic Factor in Luminal B Breast Cancer. J Breast Dis 2022 June;10(1):46-52

3. Lee C, Park I, Kim J, CHo H, Yang G, Lee Y, Park K, Kim J, Shin Y, Gwak G. Characteristics of HER2-Positive Breast Cancer according to HER2 2+/ Low or 3+/High Classification by Immunohistochemistry Assay: Study of 205 Cases Treated in a Single Center. . J Breast Dis 2021 June;9(1):1-9

4. Kim YN, Choi JH, Lee CY, Park K. Sebaceoma of the external auditory canal. Korean J Otorhinolaryngol-Head Neck Surg 2020 December;63(12):603-5

5. Baeg S, Park I, Kim J, Park C, Cho H, Yang K, Kim J, Shin Y, Park K, Gwak G. Comparative study for clinical outcomes of triple-positive and triple-negative breast cancer: long-term results in 161 patients followed in a single center. J Breast Dis 2020 June;8(1):78-84

6. Kim J, Lee Y, Yoo T, Kim J, Hyun J, Park I, Cho H, Yang K, Bae B, Kim K, Park K, Gwak G. Organ-specific recurrence or metastatic pattern of breast cancer according to biological subtypes and clinical characteristics. J Breast Dis 2019 June;7(1):30-37

7. Lee Y, Park I, Cho H, Yang K, Kim J, Park K, Gwak G. Prognostic value of estrogen and progesterone receptor expression in low proliferative human epidermal growth factor receptor 2-negative breast cancer. J Breast Dis 2017 Decmber;5(2):64-70

8. Kim JY, Bae BN, Kang G, Kim HJ, Park K. Cytokine expression associated with Helicobactor pylori and Epstein-Barr virus infection in gastric carcinogenesis. APMIS2017;125:808-815 

9. Kim HJ, Park K, Kim JY, Kang G, Gwak G, Park I. Prognostic significance of a micropapillary pattern in pure mucinous carcinoma of the breast: comparative analysis with micropapillary carcinoma. J Path Trans Med 2017;51:403-409

10. Park K, Lee JH, Han HH, Mun SG, Kang S, Cha YJ, Koo JS, Kim MJ, Lee HS, Moon J, Cho NH. Nodal metastasis signatures in breast cancer. Pathology-Research and Practice 2017;213(6):680-687

11. Kim HJ, Sung L, Kim JY, Park K. Diagnostic utility of double immunostaining of a urine cytology preparation for cytokeratin 20/p53 expression in a young woman with micropapillary urothelial carcinoma of the renal pelvis presenting as an unknown primary malignancy. CytoJournal 2016;13:26

12. Park C, Park K, Kim J, Sin Y, Park I, Cho H, Yang K, Bae BN, Kim KW, Ahn S, Gwak G. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer. World Journal of Surgical Oncology 2016;14(1):244

13. Kim JY, Park K, Kang G, Kim HJ, Gwak G, Shin YJ. Predictors of recurrent ductal carcinoma in situ after breast-conserving surgery. J Breast Cancer 2016;19(2):185-190

14. Pyo JS, Kang G, Park K. Clinicopathological significance and diagnostic accuracy of HER2 immunohistochemistry in colorectal cancer: a meta-analysis. International Journal of Biological Markers 2016;31(4):e389-e394

15. Kwon C, Sohn JH, Yoo YS, Park K. A case retropharyngeal tuberculosis presenting as a huge cystic lesion. Korean J Otorhinolaryngol-Head Neck Surg 2016;59(12):869-72

16. Kim JY, Kang G, Kim HJ, Park K, Kim KS. Immunohistochemical evaluation of CXCL12/CKCR4 and adiponectin in deep infiltrating endometriosis. Austin J of Reprod Med Infertil 2015;1023-1027

17. Cho EY, Park K, Do I, Cho J, Kim J, Lee J, Kim S, Kim KM, Sohn TS, Kang WK, Kim S. Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas. Mod Pathol 2013;26(5):677-684

18. Kim HJ, Sohn BS, Kwon JE, Kim JY, Park K. ThinPrep cytological findings of desmoplastic small round cell tumor with extensive glandular differentiation: A case study. Korean J Pathol 2013;47:182-187

19. Kim JY, Kwon JE, Kim HJ, Park K. Fine-needle aspiration cytology of abdominal wall endometriosis: a study of 10 cases. Diag Cytopathol 2013;41:115-119

20. Kim JY, Jeon TJ, Bae BN, Kwon JE, Kim HJ, Park K, Shin E. The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma. APMIS 2013;121:95-104

21. Kim HJ, Kim JE, Kang GH, Kim JY, Park K. Inflammatory pseudotumor-like follicular dendritic cell tumor of the spleen with extensive histiocytic granulomas and necrosis: a case report and literature review. Korean J Pathol 2013;47(6):599-602

22. Kim JY, Yoo YS, Kwon JE, Kim HJ, Park K. Fine-needle aspiration cytology with c-kit immunocytochemical staining in the diagnosis of Warthin's tumor. Acta Cytol 2012;56:474-480

23. Kim HJ, Kim MH, Kwon J, Kim JY, Park K, Ro JY. Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility. Annals of Diag Pathol 2012;16:411-415

24. Kim JY, Shin E, Kim HJ, Park K. Expression of Epstein-Barr virus and granzyme B in cytologic smears of histiocytic necrotizing lymphadenitis. Diagnostic Cytopathology 2012;40:792-797

25. Cho EY, Srivastava A, Park K, Kim J, Lee MH, Do I, Lee J, Kim KM, Sohn TS, Kang WK, Kim S. Comparison of four immunohistochemical tests and FISH for measuring Her2 expression in gastric carcinomas. Pathology 2012;44:216-220

26. Park K, Han S, Kim JY, Kim HJ, Kwon JE, Gwak G. Silver-enhanced in situ hybridization as an alternative to fluorescent in situ hybridization for assaying HER2 amplification in clinical breast cancer. Journal of Breast Cancer 2011;14:276-282

27. Gwak G, Park K, Shin E, Han S, Kim JY, Kim H, Kim YD, Kim HJ, Kim KW, Bae BN, Yang KH, Cho H, Park SJ. Comparison of CVF(Cyclophosphamide+Vinorelbine+5-Flurouracil) and CMF(Cyclophosphamide+Methotrexate+5-Fluorouracil) adjuvant chemotherapy in early breast cancer. Journal of Breast Cancer 2011;14:223-228

28. Park I, Park K, Han S, Kim JY, Kim KW, Bae BN, Yang GH, Gwak G, Cho H, Park S. Risk factors of locoregional recurrences in breast cancer. Korean Journal of Clinical Oncology 2011;7:66-71

29. Han D, Gwak G, Han S, Kim JY, Park K, Cho H, Yang G, Bae B, Kim K. Diagnostic value of preoperative sonographic evaluation for axillary lymph node metastases in breast cancer patients. Korean Journal of Clinical Oncology 2011;7:60-65

30. Kim HJ, Choi S, Kwon J, Kim JY, Park K. Bronchial brushing cytologic finding of pulmonary adenoid cystic carcinoma misinterpretated as small cell carcinoma - a case report with literature review -. Korean J Pathol 2011;45:441-444

31. Kim HJ, Yoo YS, Park K, Kwon JE, Kim JY, Monzon FA. Genomic aberrations in salivary duct carcinoma arising in Warthin tumor of parotid gland. Archives of Pathology Laboratory Medicine 2011;135:1088-1091

32. Kim HJ, Noh CH, Kwon G, Shin E, Kim JY, Park K. Cystic nephroma: A case report and comparing literature review with mixed epithelial and stromal tumor of kidney. Korean J Pathol 2011;45:S25-28

33. Kim JY, Bae B, Kwon J, Kim HJ, Park K. Prognostic significance if epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma. APMIS 2011;119:449-459

34. Gwak G, Kim JY, Park K, Shin YJ, Cho H, Park SJ, Yang GH, Bae BN, Kim KW, Han S. Comparison of doxorubicin plus docetaxel neoadjuvant chemotherapy with doxorubicin plus vinorelbine in primary breast cancer. Journal of Breast Cancer 2011;14:129-134

35. Gwak G, Park K, Shin E, Han S, Kim JY, Kim H, Kim YD, Kim HJ, Kim KW, Bae BN, Yang KH, Park SJ, Lim SW. Lymphovascular invasion and HER2/neu amplification as predictive factors for axillary lymph node metastasis in early breast cancer patients. Journal of Breast Cancer 2010;13:250-256

36. Yeo SG, Kim J, Kwak GH, Kim JY, Park K, Kim ES, Han S. Accelerated partial breast irradiation using multicatheter brachytherapy for select early-stage breast cancer: local control and toxicity. Radiation Oncology 2010;5:561-568

37. Han S, Park K., Shin E, Kim HJ, Kim JY, Kim JY, Gwak G. Genomic change of chromosome 8 predicts the response to taxane-based neoadjuvant chemotherapy in node-positive breast cancer. Oncology Reports 2010;24(1):121-128 

38. Lee A, Gong G, Park K., Park IA, Jung WH, Lee DW. A multi-institutional study of interlaboratory variance in the estrogen and progesterone receptor assays. J Breast Cancer 2010;13(1):46-52 

39. Han S, Kim J, Lee J, Chang E, Gwak G, Cho H, Yang G, Park S, Park K. Comparison of 6 cycles versus 4 cycles of neoadjuvant epirubicin plus docetaxel chemotherapy in stages II and III breast cancer. EJSO 2009;35;583-587

40. Shin JH, Park SJ, Cho HJ, Gwak G, Bae BN, Kim KW, Kim HY, Park K, Han S. Expression profiles of retinoblastoma protein and p27Kip according to HER2 amplification status in primary breast cancer. J Breast Cancer 2009;12(1):14-19   

41. Kim JY, Bae BN, Kim KS, Shin E, Kim HJ, Park K. Osteopontin, CD44, and NFkB expression in colorectal adenocarcinoma. Cancer Res Treat 2009;41:29-35

42. Kim JY, Bae BN, Kim KS, Shin E, Park K. Osteopontin, CD44, and NFkB expression in gastric adenocarcinoma. Basic and Applied Pathology 2008;1:168-173

43. Cho KS, Lee JS, Cho NH, Park KM, Ham WS, Choi YD. Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer. The Prostate 2008;68:803-808 

44. Cho KS, Kim DJ, Lee JS, Cho NH, Park K, Ham WS, Choi YD. Role of epidermal growth factor receptor and the HER-2 gene in hormone refractory prostate cancer. Korean J Urol 2008;49:24-30

45. Kim TG, Kim JY, Jeong MJ, Kim JH, Kim SH, Kim SH, Jun WS, Park K, Han S. Radiologic findings of granulomatous mastitis. J Korean Radiol Soc 2008;59:131-138 

46. Park K, Han S, Shin E, Kim H, Kim J. EGFR gene and protein expression in breast cancers. EJSO 2007;33;956-960

47. Han S, Kim J, Sohn S, Kwak G, Kim J, Park K. Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer. J Surg Oncol 2007;95:45-50 

48. Kim JY, Lim SJ, Kim HJ, Shin E, Park K, Lee CM. Clinical significance of p27 and Skp2 protein expression in uterine cervical neoplasm. Int J Gynecol Pathol 2007;26:242-247

49. Kim HJ, Shin E, Kim JY, Park K, Yoo YJ, Lee SS. Ki-1 positive extranodal NK/T cell lymphoma, nasal type, mistaken as dermatomyositis ? A case report and literature review ? Korean J Pathol 2007;41:278-283

50. Park K. Diagnostic pitfalls in breast fine needle aspiration cytology: false positive and false negative. Korean J Cytopathol 2007;8:112-118 

51. Jeon YK, Park K, Park CK, Paek SH, Jung HW, Park S. Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization. Neuropathology 2007;27:10-20

52. Kim SH, Koo BS, Kang S, Park K, Kim H, Lee KR, Lee MJ, Kim JM, Choi EC, Cho NH. HPV integration begins in the tosillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer 2007;120:1418-1425

53. Lim SJ, Kim HJ, Kim JY, Park K, Lee CM. Expression of HuR is associated with increased cyclooxygenase-2 expression in uterine cervical carcinoma. Int J Gynecol Pathol 2007;26(3):229-234

54. Min HS, Lee YJ, Park K, Cho BK, Park SH. Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior. Acta Neuropathol  2006;112:13-20 

55. Park K, Han S, Shin E, Kim H, Kim J. Cox-2 expression on tissue microarray of breast cancer. EJSO 2006;32:1093-1096  

56. Lim YJ, Kim J, Park K, Han S, Kim SH, Jeong MJ, Kim SH. Solitary schwannoma in the breast: a case report. J Korean Radiol Soc 2006;55:203-206 

57. Park K, Han S, Gwak G, Kim H , Kim J, Kim K. Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer. Breast Cancer Res Treat 2006;98:337-342 

58. Shim HS, Jung WH, Kim H, Park K, Cho NH. Expression of androgen receptors and inhibin/activin ? and ?A subunits in breast apocrine lesions. APMIS 2006;114:352-358 

59. Park K, Han S, Kim J, Shin E. HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry. Histopathol 2006;48:702-707 

60. Kim HJ, Lim SJ, Han S, Kim JY, Park K. Synchronous invasive ductal carcinoma and metastaticovarian serous papillary adenocarcinoma in the same breast. ? A case report - Korean J Pathol 2006;40:66-69

61. Lee JE, Soung YH, Seo SH, Kim SY, Park CH, Wang YP, Park K, Nam SW, Park WS, Kim SH, Lee JY, Yoo NJ, Lee SH. Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas. Clin Cancer Res 2006;12:57-61

62. Lim S, Kim HJ, Kim JY, Park K. Expression of CD44s is associate with the expression of cyclooxigenase-2 in non-small cell lung cancers. Korean J Pathol 2006;40:17-23

63. Kim HJ, Lim SJ, Choi H, Park K. Malignant clear-cell myomelanocytic tumor of broad ligament ? a case report. Virchows Arch 2006;448(6):867-870

64. Park K, Kwak K, Kim J, Lim S, Han S. c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of nonselected breast cancers. Hum Pathol 2005;36:634-639

65. Kim HJ, Lim S, Park K, Yuh YJ, Jang SJ, Choi J. Multiple gastrointestinal stromal tumors with a germline c-kit mutation. Pathol Int 2005;55:655-659

66. Cho NH, Park K, Kim H, Choi YD. Metastatic extramammary Paget’s disease with HER2 amplification to renal cell carcinoma: a unique presentation of cancer in cancer metastasis. Histopathol 2005;47:215-226

67. Cho NH, Choi YD, Cho NH, Park YS, Park K, Cho SH, Lee G. Lymphovascular and marginal invasion as useful prognostic indicators and the role of c-erbB-2 in patients with male extramammary Paget’s disease: a study of 31 patients. J Urol 2005;174:561-565

68. Kim JY, Lim S, Park K, Lee CM, Kim J. Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays. Gynecol Oncol 2005;97:337-341

69. Kim HJ, Lim S, Park K. Fine needle aspiration cytology of metastatic alveolar rhabdomyosarcoma mistinterpreted as carcinoma. A case report. Korean J Cytopathol 2005;16(1):52-56

70. Park K, Han S. A single institute’s experience of standardization for the HER2 status by fluorescence in situ hybridization and immunohistochemistry on a primary breast cancer tissue microarray. J Breast Cancer 2004;7:27-31

71. Cho HJ, Kwak KH, Kim JR, Sohn SC, Park K, Han S. Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer. J Korean Breast Cancer Soc 2004;7:289-293

72. Kim JY, Lim S, Park K. Cyclooxygenase-2 and c-erbB-2 expression in colorectal carcinoma assessed using tissue microarrays. Appl Immunohistochem Mol Morphol 2004;12:67-70

73. Park K, Kim J, Lim S, Han S, Lee JY. Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray. Mod Pathol 2003;16(9):937-943

74. Han S, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, Kim HY. E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide. Breast Cancer Res Treat 2003;82:11-16

75. Han S, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, Kim HY. Cyclin D1 expression and patient outcome after tamoxifen therapy in estrogen receptor positive metastatic breast cancer. Oncology Report 2003;10:141-144

76. Han S, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, Kim HY. Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer. J Surg Oncol 2003;83(4):241-247

77. Park K, Kim J, Lim S, Han S. Topoisomerase II-α(topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapy. Eur J Cancer 2003;39:631-634

78. Park K, Kim K. Comparing fluorescence in situ hybridization, immunohistochemistry, and chromogenic in situ hybridization to determine the HER2/neu status in breast cancer. Ann Oncol 2003;14(Suppl 3):iii51

79. Park K, Lim S, Kim JY, Yuh YJ, Kim SR, Kim HY. Multifocal epithelioid angiosarcoma of the stomach. A case report. Korean J Pathol 2003;37:435-437

80. Kim K, Park K, Shibata D. Relationships between adult human colonic crypts: are they close or far? Ann Oncol 2003;14(suppl 3):iii47 

81. Cho NH, Kim YB, Park TK, Kim GE, Park K, Song KJ. P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma. Gynecol Oncol 2003;91:346-353

82. Lim S, Kim JY, Park K, Kim B, Ahn G. Mullerianosis of the mesosalpinx: a case report. Int J Gynecol Pathol 2003;22(2):209-212

83. Lim S, Kim JY, Park K. Expression of p63 in lung cancer. Korean J Pathol 2003;37(2):100-107 

84. Lim S, Kim JY, Park K. Fine needle aspiration cytology of lymphoepithelial carcinoma of parotid gland: a case report. Korean J Cytopathol 2002;13(2):74-77

85. Paik S, Bryant J, Tan-Chiu E, Romond E, Hiller W, Park K, Brown A, Yothers G, Anderson S, Smith R, Wickerham DL, Wolmark N. Real-world performance of HER2 testing-National Surgical Adjuvant Breast and Bowel Project experience. J Natl Cancer Inst 2002;94:852-854

86. Park K, Kim JY, Lim S. Comparing fluorescence in situ hybridization and immunohistochemistry to determine the HER-2/neu status in breast carcinoma. Korean J Pathol 2002;36:243-248

87. Park K, Han S. Cytologic evaluation of p53, cyclin D1, and cathepsin D and their correlation with histologic sections in primary breast carcinoma. original paper. J Korean Breast Cancer Soc 2002;5:113-117

88. Park K, Han S, Kim HY, Ko I. Cytologic evaluation of cyclin D1 expression in primary breast carcinoma. Cancer(Cancer Cytopathol) 2001;93(3):211-215

89. Han S, Ahn SH, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, Kim HY. p16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy. Breast Cancer Res Treat 2001;70(3):205-212

90. Han S, Park K, Kim HY, Lee MS, Kim HJ, Kim YD, Yu YJ, Kim SR, Suh HS. Clinical implication of altered expression of Mad1 protein in human breast carcinoma. Cancer 2000;88(7):1623-1632

91. Park K, Ko I. Immunocytochemical assay of cathepsin D in fine needle aspiration cytology of breast carcinoma and benign breast disease. Korean J Cytopathol 2000;11:75-81

92. Cho JJ, Kim BS, Kim MS, Jang SJ, Chun DK, Park K. A case of cephalic brain-like hetertopia. Korean J Dermatol 2000;38(2):231-235

93. Han S, Park K, Kim HY, Lee MS, Kim HJ, Kim YD. Change of Mad1 expression in human breast cancer and normal breast tissues. J Korean Cancer Assoc 1999;31:267-274

94. Han S, Kim HY, Park K, Lee MS, Kim HJ, Kim YD, Suh HS. Reduced expression of p27 correlates with high grade malignancy and is associated with poor clinical outcome in human breast cancer. J Korean Cancer          Assoc 1999;31:492-498

95. Han S, Park K, Kim HY, Lee MS, Kim HJ, Kim YD. Reduced expression of p27Kip1 protein is associated with poor clinical outcome of the breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation. Breast Cancer Res Treat 1999;55(2):161-167 

96. Han S, Kim HY, Park K, Lee MS, Kim HJ, Kim YD. Expression of cyclin D1 protein in breast cancer and its correlation with prognosis. J Korean Surg 1999; 56:771-776

97. Han S, Kim SR, Kim BS, Ko I, Park K. 99mTc-MIBI scan in mammary Pagets disease : a case report. J Korean Med Sci 1999;14(6):675-678

98. Lee SH, Shin MS, Kim HS, Park WS, Kim SY, Lee HK, Park JY, Oh RR, Jang JJ, Park K, Han JY, Kang CS, Lee JY, Yoo NJ. Point mutations and deletions of the bcl10 gene in solid tumors and malignant lymphomas. Cancer Res 1999;59:5674-5677

99. Kim BS, Cho JJ, Koh WS, Park K. Two cases of rudimentary meningocele. Korean J Dermatol 1999;37(11):1640-1644

100. Han S, Kim HY , Park K, Cho HJ, Lee MS, Kim HJ, Kim YD. c-myc expression is related with cell proliferation and associated with poor clinical outcome in human gastric cancer. J Korean Med Sci 1999;14(5):526-530

101. Han S, Kim HY , Park K, Lee MS, Kim HJ, Kim YD. Expression of p27Kip1 and cyclin D1 protein is inversely correlated and is associated with poor clinical outcome in human gastric cancer. J Surg Oncol 1999;71(3):147-154

102. Han S, Park K , Kim HY, Lee MS, Kim HJ, Kim YD. Expression of Mad1 protein inhibits proliferation of cancer cells and inversely correlated with myc protein expression in primary gastric cancer. Oncology Report 1999;6:569-574

103. Park K, Yoo JY, Cho HJ. Correlation between expression of p53 protein and prognostic factors in meningioma. Korean J Pathol 1999;33:274-280

104. Park K, Kim Y, Woo H. Hairy polyp of soft palate in an infant. Korean J Pathol 1998;32:1101-1103 

105. Kim SH, Lee HK, Choi WC, Kim KY, Park K. Inflammatory pseudotumor of the liver. Korean J Hepatol 1998;4(1):69-76

106. Park K, Yoo J, Cho H, Cho W, Park S. Desmoplastic cerebral astrocytoma of infancy: a case report. J Korean Med Sci 1998;13(4):440-444

107. Seo SW, Kim EG, Hyun JH, Sung LH, Chung JY, Noh CH, Park K. A case of verrucous carcinoma of renal pelvis. Korean J Urol 1997;38(11):1244-1247

108. Ko I, Park K. Analysis of estrogen and progesterone receptors in breast carcinoma ? comparison of immunocytochemical assay with biochemical dextran-coated charcoal assay-. Korean J Pathol 1996;30:228-237

109. Kim SR, Yang SH, Park JH, Lee EJ, Park K, Ko IH. Immunohistochemical assay of estrogen and progesterone receptors in colorectal cancer. Korean J Med 1996;50(6):800-804 

110. Park K, Ko IH. Fine needle aspiration cytology of parasitic infestation in soft tissue. Korean J Cytopathol 1995;6(1):36-40

111. Choi WC, Park K. Liver histologic alterations following biliary obstruction in the rat. Korean J Med 1995;48(3):369-373

112. Park K, Park SY, Suh YL. Malignant Brenner tumor: report of a case. Korean J Pathol 1994;28:405-408

113. Park K, Ko I. Signet ring cell carcinoma of stomach in child: report of a case. Korean J Pathol 1994;28:102-105